End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
6.4 NZD | -0.78% | -0.62% | -3.03% |
Mar. 08 | New Zealand Shares Jump on Friday, Fisher & Paykel Healthcare's Chair to Retire | MT |
Mar. 08 | Fisher & Paykel Healthcare's Chair to Retire | MT |
Summary
- The company presents an interesting fundamental situation from a short-term investment perspective.
Strengths
- The earnings growth currently anticipated by analysts for the coming years is particularly strong.
- Before interest, taxes, depreciation and amortization, the company's margins are particularly high.
- Over the last twelve months, the sales forecast has been frequently revised upwards.
- Upward revisions of sales forecast reflect a renewed optimism among the analysts covering the stock.
- For several months, analysts have been revising their EPS estimates roughly upwards.
Weaknesses
- As estimated by analysts, this group is among those businesses with the lowest growth prospects.
- The group shows a rather high level of debt in proportion to its EBITDA.
- The company's valuation in terms of earnings multiples is rather high. Indeed, the firm is getting paid 27.88 times its estimated earnings per share for the ongoing year.
- The company's enterprise value to sales, at 3.64 times its current sales, is high.
- The company is highly valued given the cash flows generated by its activity.
- Most analysts agree on a negative opinion with regard to the stock. Indeed, the average consensus issues recommendations to underperform or sell.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Electric Utilities
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-3.03% | 5.34B | B- | ||
+9.55% | 86.73B | B | ||
-9.64% | 16.42B | C+ | ||
+10.12% | 11.3B | C+ | ||
+43.27% | 10.98B | D+ | ||
-16.20% | 10.28B | B | ||
+6.77% | 9.11B | B- | ||
+12.09% | 6.82B | C+ | ||
+0.10% | 4.35B | - | ||
-.--% | 3.84B | - | C+ |
Financials
Valuation
Momentum
Consensus
Business Predictability
Environment
Governance
Controversy
Technical analysis
- Stock Market
- Equities
- MCY Stock
- Ratings Mercury NZ Limited